Relief Reports that its U.S. Collaboration Partner has Announced that the I-SPY COVID Trial Suggests
Relief Therapeutics Holding SA / Key word(s): Study01-Apr-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Reports that its U.S. Collaboration Partner has Announced that the I-SPY COVID Trial Sponsored by Quantum...